173 related articles for article (PubMed ID: 8030546)
1. Utilization of the non-obese diabetic (NOD) mouse as an animal model for the study of secondary Sjögren's syndrome.
Humphreys-Beher MG; Hu Y; Nakagawa Y; Wang PL; Purushotham KR
Adv Exp Med Biol; 1994; 350():631-6. PubMed ID: 8030546
[No Abstract] [Full Text] [Related]
2. [Progress in understanding the pathogenesis of Sjögren's syndrome in non-obese diabetic mice].
Su YC; Wu LL; Xiang RL
Sheng Li Ke Xue Jin Zhan; 2012 Jun; 43(3):171-6. PubMed ID: 23019918
[TBL] [Abstract][Full Text] [Related]
3. Activation of TLR9-dependent p38MAPK pathway in the pathogenesis of primary Sjögren's syndrome in NOD/Ltj mouse.
Shi H; Yu CQ; Xie LS; Wang ZJ; Zhang P; Zheng LY
J Oral Pathol Med; 2014 Nov; 43(10):785-91. PubMed ID: 25065264
[TBL] [Abstract][Full Text] [Related]
4. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland.
Jonsson MV; Delaleu N; Brokstad KA; Berggreen E; Skarstein K
Arthritis Rheum; 2006 Jul; 54(7):2300-5. PubMed ID: 16802370
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C expression in salivary gland acinar epithelial cells in non-obese diabetic mice, an experimental model for Sjögren's syndrome.
Tensing EK; Ma J; Hukkanen M; Fox HS; Li TF; Törnwall J; Konttinen YT
Rheumatol Int; 2005 Jan; 25(1):28-32. PubMed ID: 13680143
[TBL] [Abstract][Full Text] [Related]
6. Role of complement and B lymphocytes in Sjögren's syndrome-like autoimmune exocrinopathy of NOD.B10-H2b mice.
Nguyen C; Cornelius J; Singson E; Killedar S; Cha S; Peck AB
Mol Immunol; 2006 Mar; 43(9):1332-9. PubMed ID: 16221495
[TBL] [Abstract][Full Text] [Related]
7. Selecting highly sensitive non-obese diabetic mice for improving the study of Sjögren's syndrome.
Xiao W; Wu Y; Zhang J; Ye W; Xu GT
Graefes Arch Clin Exp Ophthalmol; 2009 Jan; 247(1):59-66. PubMed ID: 18810481
[TBL] [Abstract][Full Text] [Related]
8. Lacrimation and salivation are not related to lymphocytic infiltration in lacrimal and salivary glands in MRL lpr/lpr mice.
Fujita H; Fujihara T; Takeuchi T; Saito I; Tsubota K
Adv Exp Med Biol; 1998; 438():941-8. PubMed ID: 9634991
[No Abstract] [Full Text] [Related]
9. Temporal changes in salivary glands of non-obese diabetic mice as a model for Sjögren's syndrome.
Roescher N; Lodde BM; Vosters JL; Tak PP; Catalan MA; Illei GG; Chiorini JA
Oral Dis; 2012 Jan; 18(1):96-106. PubMed ID: 21914088
[TBL] [Abstract][Full Text] [Related]
10. E2F-1-deficient NOD/SCID mice developed showing decreased saliva production.
Matsui-Inohara H; Uematsu H; Narita T; Satoh K; Yonezawa H; Kuroda K; Ito T; Yoneda S; Kawarai T; Sugiya H; Watanabe H; Senpuku H
Exp Biol Med (Maywood); 2009 Dec; 234(12):1525-36. PubMed ID: 19934373
[TBL] [Abstract][Full Text] [Related]
11. NOD mouse model for Sjögren's syndrome: lack of longitudinal stability.
Lodde BM; Mineshiba F; Kok MR; Wang J; Zheng C; Schmidt M; Cotrim AP; Kriete M; Tak PP; Baum BJ
Oral Dis; 2006 Nov; 12(6):566-72. PubMed ID: 17054769
[TBL] [Abstract][Full Text] [Related]
12. Hyperglycemia and Salivary Gland Dysfunction in the Non-obese Diabetic Mouse: Caveats for Preclinical Studies in Sjögren's Syndrome.
Allushi B; Bagavant H; Papinska J; Deshmukh US
Sci Rep; 2019 Nov; 9(1):17969. PubMed ID: 31784615
[TBL] [Abstract][Full Text] [Related]
13. Reversal of Sjogren's-like syndrome in non-obese diabetic mice.
Tran SD; Kodama S; Lodde BM; Szalayova I; Key S; Khalili S; Faustman DL; Mezey E
Ann Rheum Dis; 2007 Jun; 66(6):812-4. PubMed ID: 17179174
[TBL] [Abstract][Full Text] [Related]
14. Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome.
Robinson CP; Brayer J; Yamachika S; Esch TR; Peck AB; Stewart CA; Peen E; Jonsson R; Humphreys-Beher MG
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7538-43. PubMed ID: 9636185
[TBL] [Abstract][Full Text] [Related]
15. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17 Impairs Salivary Tight Junction Integrity in Sjögren's Syndrome.
Zhang LW; Cong X; Zhang Y; Wei T; Su YC; Serrão AC; Brito AR; Yu GY; Hua H; Wu LL
J Dent Res; 2016 Jul; 95(7):784-92. PubMed ID: 26933138
[TBL] [Abstract][Full Text] [Related]
17. Activation of the alternative NFκB pathway improves disease symptoms in a model of Sjogren's syndrome.
Gilboa-Geffen A; Wolf Y; Hanin G; Melamed-Book N; Pick M; Bennett ER; Greenberg DS; Lester S; Rischmueller M; Soreq H
PLoS One; 2011; 6(12):e28727. PubMed ID: 22174879
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren's Syndrome.
Klinngam W; Janga SR; Lee C; Ju Y; Yarber F; Shah M; Guo H; Wang D; MacKay JA; Edman MC; Hamm-Alvarez SF
Sci Rep; 2019 Jul; 9(1):9559. PubMed ID: 31267034
[TBL] [Abstract][Full Text] [Related]
19. IL-4-STAT6 signal transduction-dependent induction of the clinical phase of Sjögren's syndrome-like disease of the nonobese diabetic mouse.
Nguyen CQ; Gao JH; Kim H; Saban DR; Cornelius JG; Peck AB
J Immunol; 2007 Jul; 179(1):382-90. PubMed ID: 17579059
[TBL] [Abstract][Full Text] [Related]
20. E2f1 mutation induces early onset of diabetes and Sjögren's syndrome in nonobese diabetic mice.
Salam MA; Matin K; Matsumoto N; Tsuha Y; Hanada N; Senpuku H
J Immunol; 2004 Oct; 173(8):4908-18. PubMed ID: 15470032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
